Other Clinical Trial - Effect of Sugammadex for Reversal of

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02846038` - Understanding Communication in Healthcare to Achieve Trust (U-CHAT)
Completed	`NCT02537106` - A Comparison of the Effect of 1.5 Versus 3% NaCl on Brain Relaxation and Microcirculation	N/A
Completed	`NCT01951950` - Nicardipine vs Esmolol Craniotomy Emergence	Phase 1
Completed	`NCT01222780` - To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer	Phase 1
Completed	`NCT00873184` - Study of Massage Therapy Within a Brain Tumor Setting	N/A
Active, not recruiting	`NCT01115777` - Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies
Completed	`NCT00724191` - Evaluation of Human Brain Tumor Therapy Response by Magnetic Resonance (MR)
Completed	`NCT00003935` - Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma	Phase 1
Recruiting	`NCT04128306` - Brain Areas of Time-To-Contact Perception: an Awake Surgery Study	N/A
Completed	`NCT00707343` - [F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors	Phase 1
Completed	`NCT00850278` - Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors	N/A
Completed	`NCT00528437` - Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors	Phase 2
Terminated	`NCT00107471` - Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma	Phase 1/Phase 2
Completed	`NCT00187174` - Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors	Phase 1
Completed	`NCT00135876` - Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients	Phase 3
Completed	`NCT00062478` - Study of Karenitecin (BNP1350) in Patients With Brain Tumors	Phase 2
Completed	`NCT00241670` - Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid	Phase 3
Not yet recruiting	`NCT01445691` - More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery	Phase 2
Terminated	`NCT01018290` - Navigated Transcranial Magnetic Stimulation in Tumor Surgery	N/A
Completed	`NCT00003573` - Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma	Phase 2

NCT number	NCT05202899
Study type	Interventional
Source	Guangzhou General Hospital of Guangzhou Military Command
Contact	bo xu, DR
Phone	88653387
Email	xubo333@hotmail.com
Status	Recruiting
Phase	Phase 4
Start date	September 1, 2020
Completion date	May 31, 2022

Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake Craniotomy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms